Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1960 Jun;15(2):333–344. doi: 10.1111/j.1476-5381.1960.tb01253.x

Effects of ergometrine (ergonovine) on the isolated atherosclerotic heart of the cholesterol-fed rabbit

Dorothy Karp, Seymour H Rinzler, Janet Travell
PMCID: PMC1481923  PMID: 14404556

Abstract

Ergometrine usually depresses the S-T segment as in coronary insufficiency, when injected intravenously in rabbits with experimental coronary atherosclerosis and in patients with effort angina, but not in normal animals and man. To explain this difference, we carried out Langendorff perfusion studies in 32 normal and 29 atherosclerotic isolated rabbit hearts. Preliminary tests with ergometrine were done to ensure that advanced coronary atherosclerosis had developed in the rabbits fed a cholesterol diet; pathological examination of the heart after perfusion confirmed the result of the final test with ergometrine. Before drugs were perfused, the basal rate of coronary flow was greater, the heart rate was slower and the contractile amplitude was smaller in the atherosclerotic than in the normal hearts; nitroglycerin markedly increased flow in both normal and atherosclerotic groups. Ergometrine consistently caused a reduction in contractile amplitude with negligible changes in heart rate in both normal and atherosclerotic hearts. On coronary flow, however, the effects of ergometrine differed significantly in these groups; in doses of between 0.2 and 0.4 mg., the average decrease in flow was 8% in normal and 22% in atherosclerotic hearts. The effect was more variable in normal hearts and an increase in flow sometimes occurred. The difference in the response of normal and atherosclerotic hearts was particularly striking when ergometrine was given during recovery from a reduction of coronary flow which had been induced by vasopressin. Ergometrine then uniformly increased flow in the normal, but usually had the opposite effect in the atherosclerotic heart. In normal and atherosclerotic hearts, cardiac effects of vasopressin were similar. Tachyphylaxis to vasopressin, but not to ergometrine, was observed.

Full text

PDF
333

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRACHFELD N., BOZER J., GORIN R. Action of nitroglycerin on the coronary circulation in normal and in mild cardiac subjects. Circulation. 1959 May;19(5):697–704. doi: 10.1161/01.cir.19.5.697. [DOI] [PubMed] [Google Scholar]
  2. DUGUID J. B., ROBERTSON W. B. Mechanical factors in atherosclerosis. Lancet. 1957 Jun 15;272(6981):1205–1209. doi: 10.1016/s0140-6736(57)91786-5. [DOI] [PubMed] [Google Scholar]
  3. GARB S., PENNA M., SCRIABINE A. Species differences in the utilization of glucose for contractile force by isolated perfused hearts. Am J Physiol. 1955 Jan;180(1):103–106. doi: 10.1152/ajplegacy.1954.180.1.103. [DOI] [PubMed] [Google Scholar]
  4. GORLIN R., BRACHFELD N., MACLEOD C., BOPP P. Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work. Circulation. 1959 May;19(5):705–718. doi: 10.1161/01.cir.19.5.705. [DOI] [PubMed] [Google Scholar]
  5. LEE W. C., SHIDEMAN F. E. Role of myocardial catecholamines in cardiac contractility. Science. 1959 Apr 10;129(3354):967–968. doi: 10.1126/science.129.3354.967. [DOI] [PubMed] [Google Scholar]
  6. RAAB W., GIGEE W. Norepinephrine and epinephrine content of normal and diseased human hearts. Circulation. 1955 Apr;11(4):593–603. doi: 10.1161/01.cir.11.4.593. [DOI] [PubMed] [Google Scholar]
  7. RINZLER S. H., STEIN I., BAKST H., WEINSTEIN J., GITTLER R., TRAVELL J. Blocking effect of ethyl chloride spray on cardiac pain induced by ergonovine. Proc Soc Exp Biol Med. 1954 Feb;85(2):329–333. doi: 10.3181/00379727-85-20871. [DOI] [PubMed] [Google Scholar]
  8. RINZLER S. H., TRAVELL J., KARP D., CHARLESON D. Detection of coronary atherosclerosis in the living rabbit by the ergonovine stress test. Am J Physiol. 1956 Mar;184(3):605–612. doi: 10.1152/ajplegacy.1956.184.3.605. [DOI] [PubMed] [Google Scholar]
  9. RINZLER S. H., TRAVELL J., KARP D. Detection of coronary atherosclerosis in the living animal by the ergonovine stress test. Science. 1955 Jun 24;121(3156):900–902. [PubMed] [Google Scholar]
  10. STEIN I., WEINSTEIN J. Unusual reaction to ergonovine maleate in a case of coronary insufficiency. N Y State J Med. 1953 Jun 15;53(12):1454–1455. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES